Net profit of Balaxi Pharmaceuticals declined 95.42% to Rs 0.21 crore in the quarter ended September 2025 as against Rs 4.59 crore during the previous quarter ended September 2024. Sales declined 27.40% to Rs 56.18 crore in the quarter ended September 2025 as against Rs 77.38 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales56.1877.38 -27 OPM %2.0613.69 - PBDT1.866.03 -69 PBT1.385.56 -75 NP0.214.59 -95 Powered by Capital Market - Live News

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals declined 95.52% to Rs 0.29 crore in the quarter ended June 2025 as against Rs 6.48 crore during the previous quarter ended June 2024. Sales rose 7.80% to Rs 70.74 crore in the quarter ended June 2025 as against Rs 65.62 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales70.7465.62 8 OPM %5.8715.38 - PBDT1.377.87 -83 PBT0.907.37 -88 NP0.296.48 -96 Powered by Capital Market - Live News

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 August 2025.Powered by Capital Market - Live News

Balaxi Pharmaceuticals announced that the 82th Annual General Meeting(AGM) of the company will be held on 25 August 2025.Powered by Capital Market - Live News